Virtu Financial’s MABVAX THERAPEUTICS HLDGS INC MBVX Stock Holding History

Virtu Financial’s Portfolio MBVX Stock Details MBVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-12,783	Closed	-$11K	–	2570
2018 Q2	$11K	Buy	+12,783	New	+$16.2K	﹤0.01%	1901
2018 Q1	–	Sell	-33,038	Closed	-$69K	–	3034
2017 Q4	$69K	Buy	+33,038	New	+$73.1K	﹤0.01%	2007

Other funds holding MBVX

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

BCM

Biomark Capital Management Greenwich, Connecticut $8.9M AUM 97.06% 1-Year Est. Return

Virtu Financial's MBVX Position: Q3 2018 in Review

Virtu Financial sold out of MABVAX THERAPEUTICS HLDGS INC (MBVX) in Q3 2018, closing a stake of 12,783 shares — an estimated $11K sold.

Virtu Financial first reported a position in MBVX in Q4 2017 and held it in 2 quarters. The position peaked at $69K in Q4 2017. 2 funds tracked by Wall St. Rank hold MBVX as of Q3 2018.

Virtu Financial reported no remaining MABVAX THERAPEUTICS HLDGS INC position as of Q3 2018 after selling out during the quarter.
Virtu Financial sold 12,783 MABVAX THERAPEUTICS HLDGS INC shares in Q3 2018, an estimated $11K.
Virtu Financial first reported a position in MABVAX THERAPEUTICS HLDGS INC in Q4 2017 and held it in 2 quarters.
Virtu Financial's MABVAX THERAPEUTICS HLDGS INC position peaked at $69K in Q4 2017.
2 funds tracked by Wall St. Rank held MABVAX THERAPEUTICS HLDGS INC as of Q3 2018.

Based on Virtu Financial's 13F filing for Q3 2018, filed 13 Nov 2018.